Moreover, dual FAAH and MAGL inhibitors are in line with the novel approach of polypharmacology, which proposes multi-target-directed ligands (MTDLs) as potential therapeutic agents, suitable for the treatment of complex diseases, including hypertension [38,39]. Here, MGLL is linked to hypertensive disorder.